Susquehanna International Group’s Protara Therapeutics TARA Stock Holding History

Susquehanna International Group’s Portfolio TARA Stock Details TARA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$141K	Sell	27,100 -500	-2%	-$2.96K	﹤0.01%	12076
2025 Q4	$147K	Buy	+27,600	New	+$153K	﹤0.01%	11191
2025 Q3	–	Sell	-16,000	Closed	-$48.5K	–	13842
2025 Q2	$48.5K	Sell	16,000 -294,000	-95%	-$1.01M	﹤0.01%	12121
2025 Q1	$1.32M	Buy	310,000 +260,700	+529%	+$1.16M	﹤0.01%	6547
2024 Q4	$260K	Buy	+49,300	New	+$159K	﹤0.01%	10135
2024 Q3	–	Sell	-16,600	Closed	-$34.5K	–	13020
2024 Q2	$34.5K	Buy	+16,600	New	+$48.5K	﹤0.01%	11532
2021 Q4	–	Sell	-17,100	Closed	-$118K	–	13893
2021 Q3	$118K	Buy	+17,100	New	+$133K	﹤0.01%	11961

Other funds holding TARA

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

IHAM

Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Susquehanna International Group's TARA Position: Q1 2026 in Review

Susquehanna International Group increased its Protara Therapeutics (TARA) stake by 9.2% in Q1 2026, buying an estimated $57.9K and bringing the position to 116,626 shares worth $608K. The position accounts for ﹤0.01% of the portfolio, ranked #9159.

Susquehanna International Group first reported a position in TARA in Q1 2017 and has held it in 21 quarters since. The position peaked at $1.17M in Q1 2025. 114 funds tracked by Wall St. Rank hold TARA as of Q1 2026.

Susquehanna International Group held 116,626 shares of Protara Therapeutics worth $608K as of Q1 2026.
Susquehanna International Group bought 9,780 Protara Therapeutics shares in Q1 2026, an estimated $57.9K.
Protara Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9159 holding.
Susquehanna International Group first reported a position in Protara Therapeutics in Q1 2017 and has held it in 21 quarters since.
Susquehanna International Group's Protara Therapeutics position peaked at $1.17M in Q1 2025.
114 funds tracked by Wall St. Rank held Protara Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.